PMAM
BHVN

Picton Mahoney Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Picton Mahoney Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-225,000
Closed -$34M – 857
2022
Q3 		$34M Buy
225,000
+70,000
+45% +$10.6M 1.23% 7
2022
Q2 		$22.6M Buy
+155,000
New +$22.6M 0.86% 8